Filter
2433
Filtered Results: 2433
Text search:
drug
regulation
Featured
Recommendations
193
New Publications
664
Language
Document type
No document type
1408
Studies & Reports
421
Guidelines
316
Manuals
123
Strategic & Response Plan
93
Fact sheets
23
Training Material
22
Situation Updates
14
Infographics
5
Brochures
4
Resource Platforms
4
Countries / Regions
India
108
Kenya
86
Global
81
Western and Central Europe
64
Nigeria
57
South Africa
55
Uganda
54
Ethiopia
51
Tanzania
45
Sierra Leone
43
Liberia
43
Ghana
42
Bangladesh
41
Africa
39
Latin America and the Carribbean
39
Nepal
38
Zambia
37
Malawi
33
Eastern Europe
30
Myanmar / Burma
28
Ukraine
27
Philippines
25
Rwanda
24
South–East Asia Region
24
Namibia
24
Indonesia
24
Zimbabwe
20
Asia
18
Lesotho
17
Cambodia
16
Syria
15
Russia
15
Botswana
15
Eswatini/ Swaziland
14
Congo, Democratic Republic of
11
Senegal
10
Pakistan
10
Mozambique
9
Venezuela
9
Thailand
8
Middle East and North Africa
8
Brazil
8
Georgia
8
Albania
7
USA
7
Haiti
7
Germany
7
Eastern Europe and Central Asia
7
Vietnam
7
Colombia
6
Cameroon
6
Burkina Faso
6
West and Central Africa
6
China
5
Laos
5
Western Pacific Region
5
East and Southern Africa
5
Sudan
5
Iraq
5
Tajikistan
4
El Salvador
4
Chile
4
Peru
4
Guinea
4
Argentina
4
Lebanon
4
Moldova
4
South Sudan
4
North Macedonia
3
Mexico
3
Turkey
3
Benin
3
Kyrgyzstan
3
Afghanistan
3
Jordan
3
Paraguay
3
Bolivia
3
Sri Lanka
3
Libya
3
Bhutan
3
Kazakhstan
2
Iran
2
Fiji
2
Uzbekistan
2
Morocco
2
Hungary
2
Portugal
2
Spain
2
Papua New Guinea
2
Yemen
2
Poland
2
Honduras
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Singapore
1
Estonia
1
Mongolia
1
Qatar
1
Italy
1
Lithuania
1
Saudi Arabia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Belarus
1
Nicaragua
1
Greece
1
Palestine
1
Central African Republic
1
Mali
1
Angola
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
969
Clinical Guidelines
164
Public Health
141
Women & Child Health
74
Key Resources
72
Pharmacy & Technologies
45
Capacity Building
21
Toolboxes
Mental Health
245
HIV
222
AMR
198
TB
162
Pharmacy
121
COVID-19
117
Rapid Response
59
NTDs
58
NCDs
53
Planetary Health
52
Caregiver
51
Ebola & Marburg
36
Global Health Education
33
Refugee
30
Conflict
30
Disability
23
Health Financing Toolbox
16
Specific Hazards
14
Polio
12
Zika
8
Natural Hazards
7
Social Ethics
7
Cholera
6
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
Regulation of the Minister of Health of the Republic of Indonesia on Impact Reduction for Injecting Narcotics Drug Users
NAPZA : Narkotika, Psikotropika dan Zat Adiktif Lainnya (Narcotics, Psychotropic and Other Addictive Substances)
First Revised Edition
March 2000
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us...
Regulation of the Minister of Health of the Republic of Indonesia concerning guidelines for implementation of opioid replacement therapy program
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
A.55 Medicines and Related Substances Act, 2013 | No. 8 of 2013 | An Act to provide for the registration, regulation of the sale, distribution, importation, exportation, manufacture and dispensing of medicines and related substances, and matters incidental thereto.
El documento que se presenta, aborda la Prescripción desde su esencia como un proceso racional y metódico, que basándose en los antecedentes diagnósticos pertinentes, permite la mejor elección posible de los medicamentos requeridos por el paciente. Asimismo, se han incorporado algunos anteceden...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
CHAPTER 244
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
First edition, November 1997 | Revised July 2002
Three Years After Enactment of the Drug Quality and Security Act
